Today's Date: February 8, 2023
Fort Health – a New Model to Tackle the Youth Mental Health Crisis in Partnership with Pediatricians   •   Aderant Announces Strategic Partnership with Apperio   •   reVolver Podcasts Launches New Shows on Amp, the Live Radio App from Amazon   •   Children's Cancer Center Announces Vantagepoint A.I. As February Partner Of The Month   •   Seda North America Awarded Great Place to Work Certification!   •   HIGHLIGHTS ANNOUNCES LAUNCH OF KINDNESS COLLECTION DESIGNED TO CREATE CURIOUS, CREATIVE, CARING, & CONFIDENT CHILDREN   •   STAND UP TO CANCER ANNOUNCES FOUR TEAMS FOCUSED ON DIVERSITY IN EARLY PHASE CANCER CLINICAL TRIALS   •   Northwestern Mutual Accelerates ESG Momentum in 2022 Sustainability Report   •   League and HealthSparq Partner to Streamline Health Plan Member Support, Reduce Care Costs   •   Research Funding Available for Preeclampsia and Related Pregnancy Disorders   •   The Future of the Web is Here: Universe Drops Radical New Brand Campaign and Expands Tools to Empower Anyone to Own Their Corner   •   CCRM Fertility Announces Two New Office Locations in Washington, D.C. and Rockville, MD   •   Skillit Releases Inaugural Craft Intelligence Report; Reveals The Top Competitive Markets for Skilled Labor in 2023   •   Study Shows Novel Flavoprotein Fluorescence Measure is Correlated with Age-Related Macular Degeneration (AMD) Stage   •   Bridgewater Corporate Center earns ENERGY STAR certification, outperforming similar U.S. buildings on measure of energy efficien   •   40 Provider Multi-Disciplinary Practice Selects eClinicalWorks EHR and healow   •   Work-Life Imbalance Cited as Top Stressor for Working Women Today, 24 Seven Report Finds   •   Kessler Foundation grants nearly $1 million to expand employment opportunities for people with disabilities striving to work in   •   Chrissy Teigen Partners with Cord Blood Registry®   •   Walgreens Looks to Expand Diverse Suppliers Through Upcoming Virtual Summit
Bookmark and Share

Mirion Technologies to Divest Biodex Physical Medicine

ATLANTA , November 29 /Businesswire/ - Mirion Technologies, Inc. (NYSE: MIR) announced today that it has entered into a definitive agreement to sell the physical medicine assets of Biodex Medical Systems, Inc. (“Biodex”) to Salona Global Medical Device Corporation for $5 million in cash at closing and up to an additional $3 million in deferred cash payments. The deferred cash payments are contingent on the performance of the assets during the 12-month period following closing. The assets generated approximately $18 million in revenue with estimated gross margins of 30% during the most recent trailing twelve-month period.

“Divesting the physical medicine assets of Biodex enables Mirion Medical to focus on our strategic priorities and better aligns the group with Mirion’s mission of harnessing our unrivaled knowledge of ionizing radiation for the greater good of humanity,” said Mike Rossi, President of Mirion Medical. “We are pleased to see the physical medicine business in the hands of an owner whose core mission and strategy is better aligned with investing in the future of the product line and finding valued employees the right home for their skills and contributions,” said Rossi.

The transaction is subject to customary closing conditions and is expected to close on December 31st, 2022.

About Mirion

Mirion Technologies is a leading provider of detection, measurement, analysis and monitoring solutions to the nuclear, defense, medical and research end markets. The organization aims to harness its unrivaled knowledge of ionizing radiation for the greater good of humanity. Many of the company's end markets are characterized by the need to meet rigorous regulatory standards, design qualifications and operating requirements. Headquartered in Atlanta (GA – USA), Mirion employs around 2,800 people and operates in 13 countries. For more information, and for the latest news and content from Mirion, visit Mirion.com.

About Biodex Medical Systems

Biodex Medical Systems, Inc. is part of Mirion Medical, Inc., a group of healthcare-focused brands within Mirion Technologies (NYSE: MIR). Mirion Technologies, Inc. uses science and technology to drive treatment innovation across physical medicine, nuclear medicine and medical imaging categories. With a history of manufacturing and engineering excellence that spans more than 60 years, the Biodex™ mission is to provide innovative solutions and customer-driven support to medical facilities and wellness centers around the globe. Visit: Biodex.com.


STORY TAGS: Georgia, United States, North America, Health, Science, Radiology, Other Science, Medical Supplies, Divestiture,

Video

White House Live Stream
LIVE VIDEO EVERY SATURDAY
alsharpton Rev. Al Sharpton
9 to 11 am EST
jjackson Rev. Jesse Jackson
10 to noon CST


Video

LIVE BROADCASTS
Sounds Make the News ®
WAOK-Urban
Atlanta - WAOK-Urban
KPFA-Progressive
Berkley / San Francisco - KPFA-Progressive
WVON-Urban
Chicago - WVON-Urban
KJLH - Urban
Los Angeles - KJLH - Urban
WKDM-Mandarin Chinese
New York - WKDM-Mandarin Chinese
WADO-Spanish
New York - WADO-Spanish
WBAI - Progressive
New York - WBAI - Progressive
WOL-Urban
Washington - WOL-Urban

Listen to United Natiosns News